Iron Therapy Formulations
On this page
Direct answer
Oral iron remains first-line for iron deficiency: a ferrous salt delivering about 60 mg of elemental iron per dose, absorbed best on an empty stomach with a vitamin C source, away from tea and calcium — and, per modern hepcidin physiology, often given once daily or on alternate days, because splitting doses actually reduces total absorption. The response has two checkpoints examiners quote: reticulocytes peak at 7-10 days, and haemoglobin should rise about 1-2 g/dL over two to three weeks; therapy continues for about three months after haemoglobin normalises to refill stores. Intravenous iron — ferric carboxymaltose 1000 mg in a single short visit, or iron sucrose 200 mg across several visits — is reserved for intolerance, non-response, malabsorption, inflammatory bowel disease, chronic kidney disease and second-trimester anaemia needing speed. India's national programme supplements iron prophylactically at defined daily and weekly schedules under Anaemia Mukt Bharat.
What you must remember
- Oral dose anchor: ferrous sulfate 325 mg carries about 60 mg elemental iron; traditional dosing was two to three times daily, but alternate-day dosing exploits hepcidin kinetics for better fractional absorption and similar tolerance.
- Absorption choreography: empty stomach, vitamin C enhancer; tannins in tea, calcium, antacids and proton-pump inhibitors inhibit — separate by two hours.
- Response timeline: reticulocyte peak at 7-10 days; haemoglobin rise about 1 g/dL every two weeks; failure to respond means bleeding, malabsorption, non-adherence or a wrong diagnosis (thalassaemia trait, anaemia of chronic disease).
- Duration: continue about three months beyond haemoglobin normalisation — stores, not just haemoglobin, must be replete.
- Intravenous indications: genuine intolerance, ongoing losses exceeding absorption, inflammatory bowel disease, chronic kidney disease, heart failure, and pregnancy with severe anaemia in the second or third trimester.
- Formulation logic: ferric carboxymaltose 1000 mg in 15 minutes (watch for hypophosphataemia with repeats), iron sucrose 200 mg per visit (multiple doses, excellent safety), ferric derisomaltose in single large doses where available; iron dextran largely historic — anaphylaxis and test-dose era.
- Parenteral cautions: hypophosphataemia with repeated carboxymaltose (fatigue, osteomalacia), transient flushing, and test doses now confined to dextran preparations.
- Anaemia Mukt Bharat: pregnant women receive daily iron-folic acid (about 100 mg elemental iron with 500 microgram folic acid) starting early in pregnancy; school-going adolescents get weekly supplementation — quotable national numbers.
A worked outpatient pathway
A 26-year-old woman at 32 weeks of pregnancy has haemoglobin 7.8 g/dL, mean corpuscular volume 68 fL, ferritin 4 ng/mL; she has tried oral iron and stopped from dyspepsia and constipation. The decision tree writes itself. At this gestation with this severity and time running short, intravenous iron is appropriate: ferric carboxymaltose 1000 mg over about 15 minutes, with a repeat dose a week later, aiming to add 2-3 g/dL before delivery. Phosphate is checked with repeated doses. Simultaneously the oral problem is engineered away — ferrous ascorbate on alternate mornings, senna for constipation, tea separated from the dose — because she will need oral iron after delivery.
Contrast her non-pregnant twin with the same counts and menorrhagia: oral iron on alternate days for six months, tranexamic acid for the periods, and a gynaecological referral — because pharmacology fails while the loss continues. Reticulocytes at day 10 confirm the marrow's reply.
Where examiners probe
The two response numbers — reticulocyte peak at 7-10 days and the haemoglobin slope — are the most quoted pair in this whole topic, asked as "earliest laboratory marker of response" (reticulocytosis) and "expected haemoglobin rise". The second probe is dosing philosophy: the candidate who answers "twice or thrice daily, after food" is quoting the older textbook; saying "alternate-day dosing improves absorption via hepcidin, and tolerance is similar" signals current reading — and examiners in recent years have moved with that literature. The Indian-context layer is the programme arithmetic: Anaemia Mukt Bharat's daily iron-folic acid for pregnant women (about 100 mg elemental iron plus 500 microgram folic acid) and weekly supplementation for adolescents are precisely the kind of national numbers vivas harvest, since more Indian candidates will prescribe programme iron than private carboxymaltose. The classic trap closes the topic: microcytic hypochromic anaemia "refractory to iron" in a mild, well-looking adult is beta-thalassaemia trait until electrophoresis says otherwise — no amount of iron fixes globin genetics.
Frequently asked questions
Why is alternate-day oral iron dosing now preferred?
A dose of iron raises hepcidin for about 24-48 hours, blocking the next dose's absorption — spacing doses increases fractional absorption without worsening tolerance.
What is the earliest laboratory sign of response to iron?
Reticulocytosis, peaking at 7-10 days, preceding any measurable haemoglobin rise.
How long should iron continue after haemoglobin normalises?
About three months, to replete ferritin stores — stopping at normal haemoglobin guarantees relapse.
Which intravenous iron suits a single-visit 1000 mg dose?
Ferric carboxymaltose, infused over about 15 minutes, with hypophosphataemia checked on repeated courses.
What iron supplementation does Anaemia Mukt Bharat provide in pregnancy?
Daily iron-folic acid tablets — about 100 mg elemental iron with 500 microgram folic acid — starting early in pregnancy and continuing through the postpartum period.